Vasovagal syncope: an update on the latest pharmacological therapies

Bibliography

• Moya A, Sutton R, Ammirati F, et al. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J 2009;30(21):2631-71
   PubMed Web of Science ®Google Scholar
• Soteriades ES, Evans JC, Larson MG, et al. Incidence and prognosis of syncope. N Engl J Med 2002;347(12):878-85
   PubMed Web of Science ®Google Scholar
• Barón-Esquivias G, Errázquin F, Pedrote A, et al. Long-term outcome of patients with vasovagal syncope. Am Heart J 2004;147(5):883-9
   PubMed Web of Science ®Google Scholar
• Ganzeboom KS, Mairuhu G, Reitsma JB, et al. Lifetime cumulative incidence of syncope in the general population: a study of 549 dutch subjects aged 35–60 years. J Cardiovasc Electrophysiol 2006;17(11):1172-6
   PubMed Web of Science ®Google Scholar
• Goldstein DS, Spanarkel M, Pitterman A, et al. Circulatory control mechanisms in vasodepressor syncope. Am Heart J 1982;104(5 Pt 1):1071-5
   PubMed Web of Science ®Google Scholar
• Brignole M, Menozzi C, Del Rosso A, et al. New classification of haemodynamics of vasovagal syncope: beyond the VASIS classification. Europace 2000;2:66-76
   PubMed Web of Science ®Google Scholar
• Holmegard HN, Benn M, Kaijer M, et al. Prevalence of family history in patients with reflex syncope. J Clin. Neurosci 2013;20:692-6
   PubMed Web of Science ®Google Scholar
• Klein KM, Xu SS, Lawrence K, et al. Evidence for genetic factors in vasovagal syncope: a twin-family study. Neurology 2012;79:561-5
   PubMed Web of Science ®Google Scholar
• Hernández-Pacheco G, González-Hermosillo A, Murata C, et al. Arg347Cys polymorphism of α1a-adrenergic receptor in vasovagal syncope: case-control study in a mexican population. Auton Neurosci 2014;183:66-71
   PubMed Web of Science ®Google Scholar
• Holmegard HN, Benn M, Mehlsen J, et al. Genetic variation in the parasympathetic signaling pathway in patients with reflex syncope. Genet Mol Res 2013;12:2601-10
   PubMed Web of Science ®Google Scholar
• Sorrentino S, Forleo C, Iacoviello M, et al. Lack of association between genetic polymorphisms affecting sympathetic and tilt-induced vasovagal syncope. Auton Neurosci 2010;155:98-103
   PubMed Web of Science ®Google Scholar
• Klein KM, Bromhead CJ, Smith KR, et al. Autosomal dominant vasovagal syncope: clinical features and linkage to chromosome 15q26. Neurology 2013;80:1485-93
   PubMed Web of Science ®Google Scholar
• Olde Nordkamp LR, van Dijk N, Ganzeboom KS, et al. Syncope prevalence in the ED compared to general practice and population: a strong selection process. Am J Emerg Med 2009;27:271-9
   PubMed Web of Science ®Google Scholar
• Bonzi M, Fiorelli EM, Angaroni L, et al. Predictive accuracy of triage nurses evaluation in risk stratification of syncope in the emergency department. Emerg Med J 2014;31:877-81
   PubMed Web of Science ®Google Scholar
• Strickberger SA, Benson DW, Biaggioni I, et al. AHA/ACCF Scientific Statement on the evaluation of syncope: from the American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, and the Quality of Care and Outcomes Research Interdisciplinary Working Group; and the American College of Cardiology Foundation: in collaboration with the Heart Rhythm Society: endorsed by the American Autonomic Society. Circulation 2006;113(2):316-27
   PubMed Web of Science ®Google Scholar
• Forleo C, Guida P, Iacoviello M, et al. Head-up tilt testing for diagnosing vasovagal syncope: a meta-analysis. Int J Cardiol 2013;168:27-35
   PubMed Web of Science ®Google Scholar
• Bonzi M, Fiorelli EM, Furlan L, et al. Head-up tilt testing for diagnosing vasovagal syncope: a meta-analysis. Int J Cardiol 2013;168:623
   PubMedGoogle Scholar
• Krediet CTP, van Dijk N, Linzer M, et al. Management of vasovagal syncope: controlling or aborting faints by leg crossing and muscle tensing. Circulation 2002;106:1684-9
   PubMed Web of Science ®Google Scholar
• Croci F, Brignole M, Menozzi C, et al. Efficacy and feasibility of isometric arm counter-pressure manoeuvres to abort impending vasovagal syncope during real life. Europace 2004;6:287-91
   PubMed Web of Science ®Google Scholar
• Van Dijk N, Quartieri F, Blanc JJ, et al. Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope: the physical counterpressure manoeuvers trial. J Am Coll Cardiol 2006;48:1652-7
   PubMed Web of Science ®Google Scholar
• Brignole M, Croci F, Menozzi C, et al. Isometric arm counterpressure maneuvers to abort impending vasovagal syncope. J Am Coll Cardiol 2002;40:2053-9
   PubMed Web of Science ®Google Scholar
• Schroeder C, Bush VE, Norcliffe LJ, et al. Water drinking acutely improves orthostatic tolerance in healthy subjects. Circulation 2002;106:2806-11
   PubMed Web of Science ®Google Scholar
• Lu CC, Diedrich A, Tung CS, et al. Water ingestion as prophylaxis against syncope. Circulation 2003;108:2660-5
   PubMed Web of Science ®Google Scholar
• Jordan J, Shannon JR, Grogan E, et al. A potent pressor response elicited by drinking water. Lancet 1999;353(9154):723
   PubMed Web of Science ®Google Scholar
• May M, Jordan J. The osmopressor response to water drinking. Am J Physiol Regul Integr Comp Physiol 2011;300:R40-6
   PubMed Web of Science ®Google Scholar
• El-Sayed H, Hainsworth R. Salt supplement increases plasma volume and orthostatic tolerance in patients with unexplained syncope. Heart 1996;75:134-40
   PubMed Web of Science ®Google Scholar
• Cooper VL, Hainsworth R. Effects of dietary salt on orthostatic tolerance, blood pressure and baroreceptor sensitivity in patients with syncope. Clin Auton Res 2002;12:236-41
   PubMed Web of Science ®Google Scholar
• Scott WA, Pongiglione G, Bromberg BI, et al. Randomized comparison of atenolol and fludrocortisone acetate in the treatment of pediatric neurally mediated syncope. Am J Cardiol 1995;76:400-2
   PubMed Web of Science ®Google Scholar
• Salim MA, Di Sessa TG. Effectiveness of fludrocortisone and salt in preventing syncope recurrence in children: a double-blind, placebo-controlled, randomized trial. J Am Coll Cardiol 2005;45:484-8
   PubMed Web of Science ®Google Scholar
• Raj SR, Rose S, Ritchie D, et al. The second prevention of syncope trial (POST II)–a randomized clinical trial of fludrocortisone for the prevention of neurally mediated syncope: rationale and study design. Am Heart J 2006;151:1186.e11-17
   Web of Science ®Google Scholar
• Almquist A, Goldenberg IF, Milstein S, et al. Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope. N Engl J Med 1989;320:346-51
   PubMed Web of Science ®Google Scholar
• Sra JS, Murthy VS, Jazayeri MR. Use of intravenous esmolol to predict efficacy of oral beta-adrenergic blocker therapy in patients with neurocardiogenic syncope. J Am Coll Cardiol 1992;19:402-8
   PubMed Web of Science ®Google Scholar
• Nair N, Padder FA, Kutalek SP, et al. Usefulness of pindolol for treatment of neurocardiogenic syncope. Am J Cardiol 2004;94:1189-91
   PubMed Web of Science ®Google Scholar
• Cohen MB, Snow JS, Grasso V. Efficacy of pindolol for treatment of vasovagal syncope. Am Heart J 1995;130:786-90
   PubMed Web of Science ®Google Scholar
• Iskos D, Dutton J, Scheinman MM, et al. Usefulness of pindolol in neurocardiogenic syncope. Am J Cardiol 1998;82:1121-4
   PubMed Web of Science ®Google Scholar
• Abe H, Kobayashi H, Nakashima Y, et al. Effects of β-adrenergic blockade on vasodepressor reaction in patients with vasodepressor syncope. Am Heart J 1994;128:911-18
   PubMed Web of Science ®Google Scholar
• Dendi R, Goldstein DS. Meta-analysis of nonselective versus beta-1-adrenoceptor-selective blockade in the prevention of tilt-induced neurocardiogenic syncope. Am J Cardiol 2002;89:1319-21
   PubMed Web of Science ®Google Scholar
• Cox MM, Perlman BA, Mayor MR, et al. Acute and long-term beta-adrenergic blockade for patients with neurocardiogenic syncope. J Am Coll Cardiol 1995;26:1293-8
   PubMed Web of Science ®Google Scholar
• Sheldon R, Rose S, Flanagan P, et al. Effect of beta blockers on the time to first syncope recurrence in patients after a positive isoproterenol tilt table test. Am J Cardiol 1996;78:536-9
   PubMed Web of Science ®Google Scholar
• Ventura R, Maas R, Zeidler D, et al. A randomized and controlled pilot trial of β-blockers for the treatment of recurrent syncope in patients with a positive or negative response to head-up tilt test. Pacing Clin Electrophysiol 2002;25:816-21
   PubMed Web of Science ®Google Scholar
• Flevari P, Livanis EG, Theodorakis GN, et al. Vasovagal syncope: a prospective, randomized, crossover evaluation of the effect of propranolol, nadolol and placebo on syncope recurrence and patients’ well-being. J Am Coll Cardiol 2002;40:499-504
   PubMed Web of Science ®Google Scholar
• Alegria JR, Gersh BJ, Scott CG, et al. Comparison of frequency of recurrent syncope after beta-blocker therapy versus conservative management for patients with vasovagal syncope. Am J Cardiol 2003;92:82-4
   PubMed Web of Science ®Google Scholar
• Fitzpatrick AP, Ahmed S, Williams S, et al. A randomized trial of medical therapy in ‘malignant vasovagal syndrome’ or ‘neutrally-mediated bradycardia hypotension syndrome. Eur J Cardiac Electrophysiol 1991;1:99-102
   Google Scholar
• Muller G, Deal BJ, Strasburger JF, et al. Usefulness of metoprolol for unexplained syncope and positive response to tilt testing in young persons. Am J Cardiol 1993;71:592-5
   PubMed Web of Science ®Google Scholar
• Mahonanonda N, Bhuripanyo K, Kangkagate C, et al. Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and a positive upright tilt table test results. Am Heart J 1995;130:1250-3
   PubMed Web of Science ®Google Scholar
• Omar AR, Ng KS, Ng WL, et al. Reproducibility of tilt-table test result in patients with malignant neurocardiogenic syncope. Intern Med J 2004;34:504-6
   PubMed Web of Science ®Google Scholar
• Natale A, Geiger MJ, Maglio C, et al. Recurrence of neurocardiogenic syncope without pharmacologic interventions. Am J Cardiol 1996;77:1001-3
   PubMed Web of Science ®Google Scholar
• Brignole M, Menozzi C, Gianfranchi L, et al. A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope. Am J Cardiol 1992;70:339-42
   PubMed Web of Science ®Google Scholar
• Sheldon R, Rose S, Flanagan P, et al. Effect of beta blockers on the time to first syncope recurrence in patients after a positive isoproterenol tilt table test. Am J Cardiol 1996;78:536-9
   PubMed Web of Science ®Google Scholar
• Madrid AH, Ortega J, Rebollo JG, et al. Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective double-blind, randomized and placebo-controlled study. J Am Coll Cardiol 2001;37:554-9
   PubMed Web of Science ®Google Scholar
• Theodorakis GN, Leftheriotis D, Livanis EG, et al. Fluoxetine vs propranolol in the treatment of vasovagal syncope: a prospective, randomized placebo-controlled study. Europace 2006;8:193-8
   PubMed Web of Science ®Google Scholar
• Sheldon R, Connolly S, Rose S, et al. Prevention of syncope trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope. Circulation 2006;113:1164-70
   PubMed Web of Science ®Google Scholar
• Sheldon RS, Morillo CA, Klingenheben T, et al. Age-dependent effect of β-blockers in preventing vasovagal syncope. Circ Arrhythm Electrophysiol 2012;5:920-6
   PubMed Web of Science ®Google Scholar
• Coffin ST, Raj SR. Ongoing clinical trials for vasovagal syncope: where are we in 2014? Auton Neurosci 2014;184:77-82
   PubMed Web of Science ®Google Scholar
• Lamarre-Cliche M, du Souich P, de Champlain J, et al. Pharmacokinetic and pharmacodynamic effects of midodrine on blood pressure, the autonomic nervous system, and plasma natriuretic peptides: a prospective, randomized, single-blind, two-period, crossover, placebo-controlled study. Clin Ther 2008;30:1629-38
   PubMed Web of Science ®Google Scholar
• Perez-Lugones A, Schweikert R, Pavia S, et al. Usefulness of midodrine in patients with severely symptomatic neurocardiogenic syncope: a randomized control study. J Cardiovasc Electrophysiol 2001;12:935-8
   PubMed Web of Science ®Google Scholar
• Ward CR, Gray JC, Gilroy JJ, et al. Midodrine: a role in the management of neurocardiogenic syncope. Heart 1998;79:45-9
   PubMed Web of Science ®Google Scholar
• Kaufmann H, Saadia D, Voustianiouk A. Midodrine in neurally mediated syncope: a double-blind, randomized, crossover study. Ann Neurol 2002;52:342-5
   PubMed Web of Science ®Google Scholar
• Qingyou Z, Junbao D, Chaoshu T. The efficacy of midodrine hydrochloride in the treatment of children with vasovagal syncope. J Pediatr 2006;149:777-80
   PubMed Web of Science ®Google Scholar
• Klingenheben T, Credner S, Hohnloser SH. Prospective evaluation of a two-step therapeutic strategy in neurocardiogenic syncope: midodrine as second line treatment in patients refractory to β-blockers. Pacing Clin Electrophysiol 1999;22:276-81
   PubMed Web of Science ®Google Scholar
• Paling D, Vilches-Moraga A, Akram Q. Midodrine hydrochloride is safe and effective in older people with neurocardiogenic syncope. J Am Geriatr Soc 2010;58:2026-07
   PubMed Web of Science ®Google Scholar
• Mitro P, Trejbal D, Rafae R, et al. Midodrine hydrochloride in the treatment of vasovagal syncope. Pacing Clin Electrophysiol 1999;2:1620-4
   Google Scholar
• Sra J, Maglio C, Biehl M, et al. Efficacy of midodrine hydrochloride in neurocardiogenic syncope refractory to standard therapy. J Cardiovasc Electrophysiol 1997;8:42-6
   PubMed Web of Science ®Google Scholar
• Romme JJ, van Dijk N, Go-Schon IK, et al. Effectiveness of midodrine treatment in patients with recurrent vasovagal syncope not responding to non-pharmacological treatment (STAND-trial). Europace 2011;13:1639-47
   PubMed Web of Science ®Google Scholar
• Raj SR, Faris PD, McRae M, et al. Rationale for the prevention of syncope trial IV: assessment of midodrine. Clin Auton Res 2012;22:275-80
   PubMed Web of Science ®Google Scholar
• Vyas A, Swaminathan PD, Zimmerman MB, et al. Are treatments for vasovagal syncope effective?. A meta-analysis. Int J Cardiol 2012;167:1906-11
   PubMed Web of Science ®Google Scholar
• Grubb BP, Kosinski D, Mouhaffel A, et al. The use of methylphenidate in the treatment of refractory neurocardiogenic syncope. Pacing Clin Electrophysiol 1996;19:836-40
   PubMed Web of Science ®Google Scholar
• Moya A, Permanyer-Miralda G, Sagrista-Sauleda J, et al. Limitations of head-up tilt test for evaluating the efficacy of therapeutic interventions in patients with vasovagal syncope: results of a controlled study versus placebo. J Am Coll Cardiol 1995;25:65-9
   PubMed Web of Science ®Google Scholar
• Raviele A, Brignole M, Sutton R, et al. Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: a double-blind, randomized, placebo-controlled trial. Circulation 1999;99:1452-7
   PubMed Web of Science ®Google Scholar
• Biffi M, Boriani G, Sabbatani P, et al. Malignant vasovagal syncope: a randomized trial of metoprolol and clonidine. Heart 1997;77:268-72
   PubMed Web of Science ®Google Scholar
• Lee TM, Su SF, Chen MF, et al. Usefulness of transdermal scopolamine for vasovagal syncope. Am J Cardiol 1996;78:480-2
   PubMed Web of Science ®Google Scholar
• Milstein S, Buetikofer J, Dunnigan A, et al. Usefulness of disopyramide for prevention of upright tilt-induced hypotension-bradycardia. Am J Cardiol 1990;65:1339-44
   PubMed Web of Science ®Google Scholar
• Morillo CA, Leitch JW, Yee R, et al. A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt. J Am Coll Cardiol 1993;22:1943-8
   Web of Science ®Google Scholar
• Grubb BP, Wolfe DA, Samoil D, et al. Usefulness of fluoxetine hydrochloride for prevention of resistant upright tilt induced syncope. Pacing Clin Electrophysiol 1993;16:458-64
   PubMed Web of Science ®Google Scholar
• Grubb BP, Samoil D, Kosinski D, et al. Use of sertraline hydrochloride in the treatment of refractory neurocardiogenic syncope in children and adolescents. J Am Coll Cardiol 1994;24:490-4
   PubMed Web of Science ®Google Scholar
• Di Girolamo E, Di Iorio C, Sabatini P, et al. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 1999;33(5):1227-30
   PubMed Web of Science ®Google Scholar
• Kadri NN, Hee TT, Rovang KS, et al. Efficacy and safety of clonazepam in refractory neurally mediated syncope. Pacing Clin Electrophysiol 1999;22:307-14
   PubMed Web of Science ®Google Scholar
• Marquez MF, Urias-Medina K, Gomez-Flores J, et al. Comparison of metoprolol versus clonazepam as a first treatment choice among patients with neurocardiogenic syncope. Gac Med Mex 2008;144:503-7
   PubMed Web of Science ®Google Scholar
• Kanjwal K, Saeed B, Karabin B, et al. Use of octreotide in the treatment of refractory orthostatic intolerance. Am J Ther 2012;19:7-10
   PubMed Web of Science ®Google Scholar
• Schroeder C, Birkenfeld AL, Mayer AF, et al. Norepinephrine transporter inhibition prevents tilt-induced pre-syncope. J Am Coll Cardiol 2006;48:516-22
   PubMed Web of Science ®Google Scholar
• Sheldon RS, Ritchie D, McRae M, et al. Norepinephrine transport inhibition for treatment of vasovagal syncope. J Cardiovasc Electrophysiol 2013;24:799-803
   PubMed Web of Science ®Google Scholar
• United States FDA. FDA Drug Safety Communication: FDA recommends against the continued use of Meridia (sibutramine). Available from: www.fda.gov/Drugs/DrugSafety/ucm228746.htm Posted 8 October 2010 [Last accessed 27 March 2014]
   Google Scholar
• Sutton R, Salukhe TV, Franzen-McManus AC, et al. Ivabradine in treatment of sinus tachycardia mediated vasovagal syncope. Europace 2014;16:284-8
   PubMed Web of Science ®Google Scholar
• Nelson SD, Stanley M, Love CJ, et al. The autonomic and hemodynamic effects of oral theophylline in patients with vasodepressor syncope. Arch Intern Med 1991;151:2425-9
   PubMedGoogle Scholar
• Natale A, Sra J, Dhala A, et al. Efficacy of different treatment strategies for neurocardiogenic syncope. Pacing Clin Electrophysiol 1995;18:655-62
   PubMed Web of Science ®Google Scholar
• Sra JS, Jazayeri MR, Avitall B, et al. Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole. N Engl J Med 1993;328:1085-90
   PubMed Web of Science ®Google Scholar
• Romme JJ, Reitsma JB, Black CN, et al. Drugs and pacemakers for vasovagal, carotid sinus and situational syncope (Review). Cochrane Database Syst Rev 2011(10):CD004194
   Google Scholar